SomaLogic UK
Research Grant Award
Apply by 29 March 2024! Tell us in 500 words or less how high-plex proteomics analysis would advance your research.
Overview
SomaLogic is pleased to announce the very first UK Research Grant award using the SomaScan 11K Assay. One winner will receive high-plex proteomic data from 40 human plasma or serum samples, and two runners-up will receive 50% and 25% discounts, respectively. All analyses will be performed using the new SomaScan 11K Assay, enabling an unprecedented 11,000 protein measurements in plasma and serum samples.
Program details
The goal of this grant award is to assist researchers in the UK to generate pilot data for future grant applications and to promote use of the SomaScan 11K Assay as an essential tool for high quality proteomic data.
Applicants are invited to write a short proposal of 500 words or less, outlining their pilot research project, by 29 March 2024. Proposals will be reviewed within four weeks of the submission close date (29 March 2024).
A committee formed of SomaLogic staff will review and select the winning proposals based on the
following criteria:
- The overall application completeness
- Did the applicant have an original proposal with clear goals and outcomes
- Provide a clear approach and design which matches the goals and outcomes
- How the protein data and analysis are intended to be used
- What are the next steps the researcher intends to take with this additional knowledge
- How does SomaScan 11K Assay data increase insight into health and disease for their given focus area?
Winners
One winner will be awarded a fully funded project to analyze 40 samples of their choice. The two runners-up will receive either a 50% or 25% discount for the analysis of 40 samples. All samples will be processed on the SomaScan 11K Assay, together with upstream and downstream support from SomaLogic (including discussions with Technical Support to validate study design and analytical considerations – and with the project management team to arrange sample shipment and downstream bioinformatic support), excluding shipment costs to SomaLogic’s CLIA-certified lab at U.S. World Headquarters or at a SomaLogic Authorized Site. Samples must be submitted by 26 June 2024 and can only be human serum or plasma.
If applicants have any questions about sample submission requirements, they should contact us here.
Application timelines
Grant will be announced by SomaLogic and advertised via SomaLogic’s database to eligible customers in the UK.
|
Announced |
24 January 2024 |
|
Open |
24 January 2024 |
| Submission close | 29 March 2024 |
|
Winner announced |
15 May 2024 |
|
Samples submitted for processing |
26 June 2024 |
|
Data from SomaScan Assay delivered |
End of July 2024 |
Eligibility criteria
-
- The grant program terms and conditions apply and are available here.
- The grant is only open to researchers who are based in the United Kingdom and based at an institution or group where they perform the research.
- All submissions must be in English and comply with the criteria outlined here in this guide.
- The samples processed on the SomaScan 11K Assay need to be available and meet certain criteria (Handling and Processing Guide, available here).
- Pilot studies which are creative, bring new insight to health and disease, and have potential to lead to longer term studies are considered highly.
- For questions about your eligibility or to ask questions about the study you have proposed, please contact us through the form linked to at the bottom of this page.
- Only one application per person is allowed.
- Project samples submitted must be either plasma or serum.
Research grant conditions
- The one (1) winning applicant will receive SomaScan 11K Assay data for each of their 40 samples and include discussions with Technical Support to validate sample type and discuss limitations – and with the project management team to discuss sample prep/shipping and downstream bioinformatic support. Applicants will own the SomaScan 11K Assay data generated under this grant program.
- The two (2) runner-up applicants will receive either a 50% discount or 25% discount on SomaScan 11K Assay data for each of their 40 samples and include discussions with Technical Support to validate sample type and discuss limitations – and with the project management team to discuss sample prep/shipping and downstream bioinformatic support. Applicants will own the SomaScan 11K Assay data generated under this grant program. The discount will be applied on final invoicing.
- Additional samples can be added to the 40 samples at full price.
- Samples sent must be plasma or serum only.
- Samples will be run on the SomaScan 11K Assay by SomaLogic at their facility in the USA or at a SomaLogic
Authorized Site. - Application submission deadline is 29 March 2024. Any submission made after this date will not be accepted.
- Successful applicants consent to their name and organization being used for promotional purposes under
this grant program. - The winner will be announced 15 May 2024 by email and social media (Facebook, Twitter, LinkedIn) and will
be encouraged to present their research in SomaLogic marketing activities. - For questions about your eligibility or to ask questions about the study you have proposed, please contact us here.
- The grant is for research purposes only and not to be used for commercial or clinical purposes.
- The applications will be reviewed by a SomaLogic committee, and a winner and runners-up decided by
same. - SomaLogic decision is final on study feasibility.
- All entrants agree to be contacted by SomaLogic for marketing purposes.
- Special grant terms and conditions here apply.
Sample submission
- The grant winner will provide 40 samples of plasma or serum to be run on the SomaScan 11K Assay with the output product being data showing signaling for 11,000 protein targets.
- The grant runners-up will provide 40 samples of plasma or serum to be run on the SomaScan 11K Assay with the output product being data showing signaling for 11,000 protein targets.
- Samples must be human plasma or serum. Other sample types may be considered after consultation.
- Samples submitted must be 130 µl volume and have been prepared according to the SomaLogic Handling and Processing Guide (available here). Recording, delivery and labelling will be discussed with the winners.
- Sample submissions, including any associated documentation, cannot include any personal or health
information on human subjects. Awardees agree to comply with all applicable laws and regulations with
their grant submission and, if awarded, their sample submissions. - Shipment of samples must be to the awardee expense via suitable cold chain courier with dry ice top up, and preferably tracking.